Guardant Health Announces Board and Executive Compensation Changes
Ticker: GH · Form: 8-K · Filed: Jul 18, 2024 · CIK: 1576280
| Field | Detail |
|---|---|
| Company | Guardant Health, Inc. (GH) |
| Form Type | 8-K |
| Filed Date | Jul 18, 2024 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.00001, $362,500 |
| Sentiment | neutral |
Sentiment: neutral
Topics: governance, executive-compensation, board-changes
Related Tickers: GH
TL;DR
Guardant Health swapped a board member and tweaked exec pay. Watch for strategy shifts.
AI Summary
Guardant Health, Inc. announced on July 17, 2024, changes in its board of directors and executive compensation arrangements. Specifically, the company reported the departure of a director and the election of a new director, along with updates to compensatory arrangements for certain officers.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — This filing primarily concerns routine corporate governance and executive compensation updates, which typically carry low immediate risk.
Key Players & Entities
- Guardant Health, Inc. (company) — Registrant
- July 17, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 3100 Hanover Street Palo Alto, California 94304 (address) — Principal executive offices
- 855-698-8887 (phone_number) — Registrant's telephone number
FAQ
Who is the new director elected to the board?
The filing indicates the election of a new director but does not name the individual in the provided text.
Which director has departed from the board?
The filing reports the departure of a director but does not specify their name in the provided text.
What specific changes were made to executive compensation arrangements?
The filing states that there were updates to compensatory arrangements for certain officers, but the details of these changes are not provided in the excerpt.
What is the primary reason for this 8-K filing?
This 8-K filing is to report on the departure of a director, the election of a new director, and changes to compensatory arrangements of certain officers.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on July 17, 2024.
Filing Stats: 1,069 words · 4 min read · ~4 pages · Grade level 11 · Accepted 2024-07-18 17:19:32
Key Financial Figures
- $0.00001 — ange on which registered Common Stock, $0.00001 par value per share GH The Nasdaq G
- $362,500 — stock unit award, each with a value of $362,500 (collectively, the "Initial Awards"). E
Filing Documents
- d771601d8k.htm (8-K) — 28KB
- d771601dex991.htm (EX-99.1) — 5KB
- g771601dsp6.jpg (GRAPHIC) — 9KB
- 0001193125-24-181093.txt ( ) — 165KB
- gh-20240717.xsd (EX-101.SCH) — 3KB
- gh-20240717_lab.xml (EX-101.LAB) — 17KB
- gh-20240717_pre.xml (EX-101.PRE) — 11KB
- d771601d8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release of Guardant Health, Inc., dated July 18, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GUARDANT HEALTH, INC. Date: July 18, 2024 By: /s/ John G. Saia John G. Saia Chief Legal Officer and Corporate Secretary